Cardiovascular Division, Academic Department of Vascular Surgery, St Thomas' Hospital, King's College London, London, UK.
Department of Interventional Radiology, Guys and St Thomas Hospital, London, UK.
J Vasc Surg Venous Lymphat Disord. 2022 Sep;10(5):1051-1058.e3. doi: 10.1016/j.jvsv.2022.03.006. Epub 2022 Mar 28.
Acute iliofemoral deep vein thrombosis (DVT) is associated with the development of post-thrombotic syndrome (PTS). Thrombolysis and deep venous stenting can restore vessel outflow and can reduce the incidence of PTS. However, for a proportion of patients, subsequent stenosis or reocclusion will necessitate further intervention. In the present study, we aimed to identify the risk factors, examine the outcomes (reintervention success and PTS), and develop a classification system for reintervention.
A retrospective single-center cohort study of patients who had undergone successful lysis for iliofemoral DVT from 2013 to 2017. The patients' records and imaging studies were examined for demographics, risk factors, extent of thrombus and vessel clearance, stenting, flow, reintervention, anticoagulation compliance, Villalta score, and secondary patency. From our findings, a system of classification for patients for whom procedures have failed was developed, constituting technical, hematologic, flow related, or multiple factors.
Of 143 limbs (133 patients), 48 (33.6%) had required reintervention, of which 25 had presented with reocclusion (17.4%). The median time to reintervention was 45 days. The need for reintervention was associated with inferior vena cava thrombus (risk ratio [RR], 2.16; P < .01), stenting across the inguinal ligament (RR, 2.08; P < .01), and anticoagulation noncompliance (RR, 7.09; P < .01). Successful reintervention was achieved in 31 limbs (64.6%): 23 of 23 (100%) treated before occlusion vs 8 of 25 (36.4%) treated after occlusion (RR, 32.31; P < .01). A greater incidence of any PTS was observed for patients requiring reintervention (median Villalta score, 3 [interquartile range, 1-5]; vs 1 [interquartile range, 1-4]; RR, 2.28; P = .029). Cases without complete vessel occlusion (reintervention and control) had a lower rate of any PTS (14.0% vs 42.9%; RR, 3.06; P < .01) and moderate to severe PTS (3.0% vs 14.3%; RR, 4.76; P = .046) Technical issues were observed in 54.2% of reintervention cases and 6.3% of cases not requiring reintervention (P < .01). Hematologic issues were identified in 33.3% of reintervention cases and 1.1% of cases not requiring reintervention (P < .01). Flow-related issues were observed in 43.8% of the reintervention cases and no cases not requiring reintervention (P < .01). Of the reintervention cases, 27.1% were multifactorial and were associated with a lower rate of vessel salvage; however, this did not translate into a significant difference in secondary patency on survival analysis (RR, 1.70; P = .429).
A large proportion of patients required reintervention because of potentially preventable factors. Anticoagulation compliance, thrombus burden, and poor flow are important risk factors to consider in patient selection. Reintervention increased the risk of PTS and was more often successful when achieved before vessel occlusion.
急性髂股深静脉血栓形成(DVT)与血栓后综合征(PTS)的发生有关。溶栓和深静脉支架置入术可以恢复血管流出,降低 PTS 的发生率。然而,对于一部分患者,随后的狭窄或再闭塞将需要进一步干预。在本研究中,我们旨在确定风险因素,检查(再干预成功和 PTS)结果,并建立再干预分类系统。
回顾性分析 2013 年至 2017 年期间接受成功溶栓治疗的髂股 DVT 患者的单中心队列研究。检查患者的记录和影像学研究,以了解人口统计学、风险因素、血栓和血管清除程度、支架置入、血流、再干预、抗凝依从性、Villalta 评分和继发性通畅情况。根据我们的发现,为治疗失败的患者制定了分类系统,包括技术、血液学、血流相关或多种因素。
143 条肢体(133 例患者)中有 48 条(33.6%)需要再次干预,其中 25 条出现再闭塞(17.4%)。再干预的中位时间为 45 天。需要再次干预与下腔静脉血栓(风险比 [RR],2.16;P<0.01)、股静脉跨骼韧带支架置入(RR,2.08;P<0.01)和抗凝不依从(RR,7.09;P<0.01)有关。31 条肢体(64.6%)成功进行了再干预:23 条在闭塞前治疗(100%)与 25 条在闭塞后治疗(36.4%)相比(RR,32.31;P<0.01)。需要再次干预的患者 PTS 发生率更高(中位数 Villalta 评分,3 [四分位间距,1-5];与 1 [四分位间距,1-4];RR,2.28;P=0.029)。无完全血管闭塞(再干预和对照组)的病例 PTS 发生率较低(14.0%与 42.9%;RR,3.06;P<0.01)和中重度 PTS 发生率较低(3.0%与 14.3%;RR,4.76;P=0.046)。在 54.2%的再干预病例中观察到技术问题,而在不需要再次干预的病例中为 6.3%(P<0.01)。在 33.3%的再干预病例和 1.1%的不需要再次干预的病例中发现血液学问题(P<0.01)。在 43.8%的再干预病例和无需要再次干预的病例中观察到血流相关问题(P<0.01)。在再干预病例中,27.1%为多因素,与血管再通率较低有关;然而,这并没有转化为生存分析中继发性通畅率的显著差异(RR,1.70;P=0.429)。
由于潜在可预防的因素,很大一部分患者需要再次干预。抗凝依从性、血栓负荷和血流不良是患者选择中重要的风险因素。再干预增加了 PTS 的风险,并且在血管闭塞前进行时更有可能成功。